Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amphastar Pharma (NQ: AMPH)
20.47 USD  +0.25 (+1.24%)
Official Closing Price  /  Updated: 6:07 PM EDT, Jun 25, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 129,282
Open 20.36
Bid (Size) 20.20 (3)
Ask (Size) 23.30 (1)
Prev. Close 20.22
Today's Range 20.31 - 20.73
52wk Range 15.04 - 25.43
Shares Outstanding 46,614,060
Dividend Yield N/A
Performance
YTD
+3.59%
+3.59%
1 Month
-0.15%
-0.15%
3 Month
+0.15%
+0.15%
6 Month
+7.51%
+7.51%
1 Year
+31.64%
+31.64%
Top News
More News
Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Jason Shandell, President, will be presenting at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at... Read More
from GlobeNewswire News Releases
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) today announced that it has entered into a settlement agreement (the “Settlement Agreement”) with Momenta Pharmaceuticals Inc. and Sandoz Inc.,... Read More
from GlobeNewswire News Releases
More News
Read More
Amphastar Pharmaceuticals to Present at the Raymond James Life Sciences and MedTech Healthcare Conference
from GlobeNewswire News Releases
Amphastar Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
from GlobeNewswire News Releases
Amphastar Pharmaceuticals to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
from GlobeNewswire News Releases
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
from GlobeNewswire News Releases
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2019
from GlobeNewswire News Releases
Market Trends Toward New Normal in Cheniere Energy, CoreSite Realty, CalAmp, NextEra Energy Partners, LP, NewLink Genetics, and Amphastar Pharmaceuticals — Emerging Consolidated Expectations, Analyst
from GlobeNewswire News Releases
Amphastar Pharmaceuticals Receives FDA Approval for Enoxaparin Sodium Injection 300mg/3mL (100mg/mL) Multiple Dose Vial
from GlobeNewswire News Releases
Analysts Anticipate IJR To Hit $89
category ETFs
from ETF Channel
RZG's Holdings Could Mean 13% Gain Potential
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
© Copyright FinancialContent Services, Inc.